TNF and diabetes mellitus: Our list reports three tumor necrosis factor (TNF) inhibitors (HUMIRA, ENBREL, and REMICADE), two Janus kinase (JAK) inhibitors (RINVOQ, XELJANZ XR), two immune system modulators (COSENTYX, VEDOLIZUMAB), a lipid-lowering drug (ALLI), and a diabetes-lowering drug (TRULICITY).